Botanical species · safety record

Corydalis yanhusuo

The EFSA Compendium of Botanicals holds 3 constituent measurements for Corydalis yanhusuo. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Corydalis yanhusuo (Y.H.Chou & Chun C.Hsu) W.T.Wang ex Z.Y.Su & C.Y.Wu

3Constituent measurements

0Safety records

2Cited sources

219Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 219 licensed products naming Corydalis yanhusuo as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Dried tuber
Dried tuber (processed)
New material
Rhizome
Rhizome (Processed with vinegar)
Rhizome (processed)
Rhizome Extract
Rhizome(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Roots and other underground parts	Solvent extraction	≥ 0.467 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Alkaloids	Roots and other underground parts	Solvent extraction	≤ 0.882 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Isoquinoline alkaloids	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Sun, Tingting., Zhang, Zhijie., Lee, Raorao., Gong, Qianfeng., Qin, Hailin. QUANTITATIVE DETERMINATION AND VARIATION TRENDS OF SIX ALKALOIDS IN CRUDE AND PROCESSED CORYDALIS YANHUSUO. ANALYTICAL LETTERS, 2013, vol. 46, no. 16, p. 2542-2556. DOI
Xiao, Hai-Tao., Peng, Jiao., Liang, Yan., Yang, Jie., Bai, Xue., Hao, Xiao-Yan., Yang, Fu-Mei., Sun, Qian-Yun. Acetylcholinesterase inhibitors from Corydalis yanhusuo. NATURAL PRODUCT RESEARCH, 2011, vol. 25, no. 15, p. 1418-1422. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature